-+ 0.00%
-+ 0.00%
-+ 0.00%

TRAWS PHARMA - DEFERS PLANNED PHASE 2A INFLUENZA STUDY OF TIVOXAVIR MARBOXIL AFTER NEGATIVE UK MHRA REVIEW - SEC FILING

Reuters·06/12/2026 21:26:54

Please log in to view news